We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTM:NYSEWhite Mountains Insurance Group, Ltd. Analysis

Data as of 2026-05-11 - not real-time

$2,128.40

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

White Mountains Insurance Group (WTM) trades at a strikingly low PE of 5.3 versus an industry average of 16.4, and its price‑to‑book ratio sits just under 1, suggesting a deep value position. The stock is currently priced at $2,128, below its recent book value of $2,170 and the 20‑day SMA of $2,231, yet the 30‑day volatility of 23.9% and a beta of only 0.35 indicate modest price swings and low market sensitivity. Technical signals are mixed: a bullish trend and rising volume support upside, but a bearish MACD and an RSI around 39 point to lingering downside pressure. The dividend yield of 5% with a minuscule payout ratio (0.25%) makes the payout highly sustainable.
Revenue has slipped 10.8% YoY and operating margins are razor‑thin, while net debt is modest relative to cash, leaving the company net cash‑rich. Recent material news notes a 1% decline in book value and an acquisition by White Mountains Partners, hinting at strategic expansion but also adding integration risk. Given the DCF‑derived fair value of roughly $1,647, the market appears to price in a premium, but the combination of cheap relative multiples and strong balance‑sheet liquidity keeps the stock attractive for value‑oriented investors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near support and oversold RSI
  • Strong cash position and sustainable dividend
  • Increasing volume indicating buying interest

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Cheap valuation multiples versus peers
  • Revenue decline and thin operating margins
  • Potential upside from strategic acquisition

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • DCF fair value far below current price
  • High leverage relative to equity
  • Limited growth prospects in core insurance lines

Key Metrics & Analysis

Financial Health

Revenue Growth-10.80%
Profit Margin37.02%
P/E Ratio5.3
ROE19.67%
ROA3.32%
Debt/Equity13.52
P/B Ratio1.0
Op. Cash Flow$621.2M
Free Cash Flow$246.3M
Industry P/E16.4

Technical Analysis

TrendBullish
RSI38.7
Support$2,050.01
Resistance$2,333.00
MA 20$2,231.07
MA 50$2,215.40
MA 200$2,007.69
MACDBearish
VolumeIncreasing
Fear & Greed Index90.73

Valuation

Fair Value$1,646.91
GradeOvervalued
TypeValue
Dividend Yield0.05%

Risk Assessment

Beta0.35
Volatility23.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.